Business ❯ Pharmaceuticals ❯ Drug Development ❯ Weight Loss Medications

Novo Nordisk

U.S. Obesity Rate Drops to 37% as GLP-1 Use Surges, Gallup Finds

Insurance limits could prevent the decline from enduring.